NCT04724668View on ClinicalTrials.gov

The Role of the Circadian System in Binge Eating Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Binge-Eating DisorderCircadian Rhythm Disorders
Interventions
DIETARY_SUPPLEMENT

Melatonin (3hrs before DLMO)

Melatonin 3mg (3hrs before DLMO)

DIETARY_SUPPLEMENT

Placebo (3hrs before DLMO)

Placebo capsule (3hrs before DLMO)

DEVICE

Morning light version 1

Morning light version

DEVICE

Morning light version 2

Morning light version

Trial Locations (1)

45040

Lindner Center of HOPE / University of Cincinnati, Mason

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Lindner Center of HOPE

OTHER

lead

University of Cincinnati

OTHER

NCT04724668 - The Role of the Circadian System in Binge Eating Disorder | Biotech Hunter | Biotech Hunter